| CAS ID: | 1604015-18-0 |
| Molecular Formula: | |
| Molecular Weight: | g/mol |
| Monoisotopic Mass: | g/mol |
| Class: | Unknown |
| Natural Product: | No |
| Other Names: | |
| Analysis: | N/A |
Trial Record 1
| ClinicalTrial ID | NCT02421094 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | April 20, 2015 | Last Verified | July 11, 2017 |
| Sponsor | Galectin Therapeutics Inc. | ||
Trial Record 2
| ClinicalTrial ID | NCT02462967 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | June 4, 2015 | Last Verified | February 14, 2018 |
| Sponsor | Galectin Therapeutics Inc. | ||
Trial Record 3
| ClinicalTrial ID | NCT01899859 | Disease | Liver fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | July 16, 2013 | Last Verified | February 23, 2015 |
| Sponsor | Galectin Therapeutics Inc. | ||